Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/614446


Bausch & Lomb Incorporated - Healthcare - Medical Equipment SWOT Report


Description: Bausch & Lomb Incorporated - Healthcare - Medical Equipment SWOT Report is a comprehensive report of the company including both quantitative and qualitative research. The report examines the company’s business structure and operations, history and products. The report provides strategic insight on the company in the form of a SWOT analysis. This studies the major internal factors which will affect the company’s performance e.g. size, strength, cost, revenues and strategy as well as external factors e.g. competitive positioning and industry trends. There is a forward-looking discussion of the opportunities the company can exploit and the threats facing it.

Scope

- Critical appraisal of the company’s positioning using SWOT analysis.
- Company information, including business descriptions, company history, product lines, key competitors and key employee biographies.

Reasons to buy

- Support business/sales activities by understanding customers businesses better.
- Identify prospective partners and suppliers.
- Capitalize on your competitors weaknesses and target the market opportunities available to them.


Contents: 1 3
1.1 List of Tables 9
2 Company Snapshot 10
2.1 Key Information 10
2.2 Company Overview 10
2.3 Financial Performance 10
3 Business Description 11
3.1 Business Overview 11
3.2 Cataract and Vitreoretinal Surgery Product Category 11
3.2.1 Overview 11
3.2.2 Financials 11
3.3 Contact Lenses Product Category 11
3.3.1 Overview 11
3.3.2 Financials 11
3.3.3 Market View 11
3.4 Lens Care Product Category 12
3.4.1 Overview 12
3.4.2 Financials 12
3.4.3 Market View 12
3.4.4 Key Strategies 12
3.5 Pharmaceuticals Category 12
3.5.1 Overview 12
3.5.2 Financials 12
3.5.3 Key Strategies 12
3.6 Refractive Surgery Product Category 13
3.6.1 Overview 13
3.6.2 Financials 13
3.6.3 Key Strategies 13
3.7 Major Products and Services 13
3.7.1 Overview 13
4 History 14
5 SWOT Analysis 17
5.1 Overview 17
5.2 Bausch & Lomb Incorporated Strengths 17
5.2.1 Diversified global presence 17
5.2.2 Comprehensive product portfolio 17
5.2.3 Brand value 17
5.3 Bausch & Lomb Incorporated Weaknesses 18
5.3.1 Weak revenue growth 18
5.3.2 Product recalls 18
5.3.3 Low returns 18
5.4 Bausch & Lomb Incorporated Opportunities 18
5.4.1 Collaborations 18
5.4.2 FDA approvals 18
5.4.3 Emerging vitamin and nutrition market 18
5.5 Bausch & Lomb Incorporated Threats 19
5.5.1 FDA warning 19
5.5.2 Stringent reimbursement policies 19
6 Competitors 20
7 Key Employees 21
8 Key Employee Biographies 22
9 Locations And Subsidiaries 24
9.1 Head Office 24
9.2 Other Locations & Subsidiaries 24
10 Recent Developments 26
10.1 Financial Announcements 26
10.1.1 Aug 08, 2007: Bausch & Lomb Reports Q2 2007 Results 26
10.1.2 Jul 24, 2007: Bausch & Lomb Declares Quarterly Dividend 26
10.1.3 May 10, 2007: Bausch & Lomb Preliminary Q1 2007 Results 26
10.1.4 May 01, 2007: Bausch & Lomb Declares Quarterly Dividend 27
10.1.5 Mar 06, 2007: Bausch & Lomb Reports Preliminary Q4 And 2006 Results 27
10.1.6 Feb 26, 2007: Bausch & Lomb Declares Quarterly Dividend 28
10.1.7 Nov 09, 2006: Bausch & Lomb Reports Preliminary Q3 2006 Results 28
10.1.8 Nov 07, 2006: Bausch & Lomb Declares Quarterly Dividend 29
10.1.9 Jul 25, 2006: Bausch & Lomb Declares Quarterly Dividend 29
10.1.10 May 02, 2006: Bausch & Lomb Declares Quarterly Dividend 29
10.2 Corporate Communications 29
10.2.1 Aug 18, 2008: Bausch & Lomb Announces Senior Management Appointments 29
10.2.2 Jul 23, 2008: Bausch & Lomb Appoints CIO 30
10.2.3 Jul 01, 2008: Bausch & Lomb Appoints CTO 30
10.2.4 Jun 24, 2008: Bausch & Lomb Appoints Vice President, Global Clinical & Medical Affairs And Professional Services, Vision Care 31
10.2.5 May 05, 2008: Bausch & Lomb Announces Management Changes 31
10.2.6 Mar 06, 2008: Bausch & Lomb Appoints CVP, CHRO 32
10.2.7 Feb 05, 2008: Bausch & Lomb Appoints New Directors 32
10.2.8 Jan 23, 2008: Bausch & Lomb Appoints New CEO 33
10.2.9 Nov 20, 2007: Bausch & Lomb Appoints Corporate VP And General Counsel 33
10.2.10 Oct 04, 2007: Bausch & Lomb Appoints Corporate Vice President And President, Asia Pacific Region 34
10.2.11 Jul 05, 2007: Bausch & Lomb Appoints Corporate Vice President And President, US Vision Care 34
10.2.12 May 23, 2007: Bausch & Lomb Appoints Vice President, Global R&D Vision Care 34
10.2.13 Mar 19, 2007: Bausch & Lomb CFO Retires 35
10.2.14 Mar 19, 2007: Bausch & Lomb Appoints New CFO 35
10.2.15 Feb 19, 2007: Bausch & Lomb Adds New Board Member 35
10.2.16 Jan 05, 2007: Bausch & Lomb Announces Management Changes 35
10.2.17 Dec 22, 2006: Bausch & Lomb’s Listing On NYSE Extended 36
10.2.18 Apr 19, 2006: Bausch & Lomb Names New President For Its Asia Region 36
10.3 Legal and Regulatory 36
10.3.1 Jun 20, 2008: Bausch & Lomb Sues Lexington Insurance 36
10.3.2 May 21, 2008: Bausch & Lomb Sued In St. Clair County 37
10.3.3 Aug 20, 2007: Bausch & Lomb And Alcon Settle Advertising Lawsuit 37
10.3.4 Jul 02, 2007: Bausch & Lomb Sued By Parker Waichman 38
10.3.5 Jun 26, 2007: Bausch & Lomb Files Suit Against Alcon 38
10.3.6 Nov 06, 2006: Bausch & Lomb Receives FDA Warning Letter Related To Inspection At Greenville 39
10.4 Government and Public Interest 39
10.4.1 Jun 10, 2008: FDA Panel Recommends Stricter Contact Lens Labeling 39
10.5 Product News 40
10.5.1 Apr 11, 2008: Bausch & Lomb To Donate Up To $400,000 to Susan G. Komen for the Cure Through ReNu MultiPlus Solution Campaign 40
10.5.2 Apr 09, 2008: Interim results of hydrophilic acrylic IOL show good visual function, centration 40
10.5.3 Apr 07, 2008: Bausch & Lomb Lens Wins 2008 Medical Design Excellence Awards Competition 41
10.5.4 Apr 07, 2008: Bausch & Lomb Lens Wins 2008 Medical Design Excellence Awards Competition 41
10.5.5 Apr 02, 2008: Gift Of Sight Given To 100 People In 100 Minutes 41
10.5.6 Sep 26, 2007: Bausch & Lomb Partners with Susan G. Komen for the Cure to Fight Breast Cancer 42
10.5.7 Sep 26, 2007: Bausch & Lomb Partners with Susan G. Komen for the Cure to Fight Breast Cancer 42
10.5.8 Sep 07, 2007: Bausch & Lomb Launches The Stellaris Vision Enhancement System In Europe at ESCRS 2007 42
10.5.9 Jul 13, 2007: The Five Myths of Monovision Correction of Presbyopia 43
10.5.10 May 31, 2007: Reversible Speculum 43
10.5.11 Jan 18, 2007: Akreos MI-60 Lens European Launch 43
10.5.12 Dec 13, 2006: Comparison of Pentacam and Orbscan IIz on Posterior Curvature Topography Measurements in Keratoconus Eyes 43
10.5.13 Dec 01, 2006: Devgan Cataract System 44
10.5.14 Nov 11, 2006: Bausch & Lomb Showcases New Technologies At American Academy Of Ophthalmology Annual Meeting 44
10.5.15 Nov 11, 2006: Bausch & Lomb Showcases New Technologies at American Academy of Ophthalmology Annual Meeting 44
10.5.16 Sep 01, 2006: Fluidics and Heat Generation of Alcon Infiniti and Legacy, Bausch & Lomb Millennium, and Advanced Medical Optics Sovereign Phacoemulsification Systems 44
10.5.17 Aug 08, 2006: Bausch & Lomb Receives FDA Approval for Plasma Treatment of Gas-Permeable Contact Lenses 45
10.5.18 Aug 07, 2006: MAXSIGHT In News 45
10.5.19 Aug 05, 2006: MAXSIGHT MAKING NEWS 45
10.5.20 Jul 15, 2006: Nike Maxsight sees sport better 45
10.5.21 May 15, 2006: Surgeons describe performance of Zyoptix XP device compared with other flap-creation technology 46
10.5.22 Feb 23, 2006: Bausch & Lomb GP Materials Receive Expanded FDA Post-Surgical Indications 46
10.5.23 Feb 23, 2006: BostonXO®, and EO Gas Permeable Contact Lenses Receive Clearance for Use Following Penetrating Keratoplasty or Refractive Surgeries 46
10.5.24 Feb 01, 2006: Cataract surgery and lens implantation 46
10.5.25 Jan 31, 2006: Anika Therapeutics--An Injection for Growth 47
10.5.26 Nov 18, 2005: Specialty Lenses Continue to Lead Contact Lens Growth 47
10.5.27 Nov 01, 2005: Posterior capsule opacification after implantation of a hydrogel intraocular lens 47
10.5.28 Oct 31, 2005: Determining corneal power using Orbscan II videokeratography for intraocular lens calculation after excimer laser surgery for myopia 47
10.5.29 Oct 12, 2005: Bausch & Lomb Offers Retina Surgeons Easy Access to Next-Generation Millennium TSV25 Technology Upgrades 48
10.5.30 Oct 10, 2005: The Zyoptix XP: An Advance in Mechanical Microkeratome Technology 48
10.5.31 Sep 03, 2005: Global contact lens revenues are expected to grow 48
10.5.32 Feb 01, 2005: Reproducibility of Self-Measured Intraocular Pressure With the Phosphene Tonometer in Patients With Ocular Hypertension and Early to Advanced Glaucoma. 48
10.5.33 Dec 31, 2004: Performance of SofLens 49
10.5.34 Dec 10, 2004: Millennium Phaco System Undergoes Enhancements 49
10.5.35 Aug 08, 2004: Contact Lens 49
10.5.36 Apr 04, 2004: Bausch & Lomb and CIBA Vision Announce Final Global Settlement of Patent Litigation 49
10.5.37 Mar 27, 2004: Growth in revenue by addition of Soflens to our contact lens portfolio 50
10.5.38 Dec 03, 2003: The Effect of Artificial Tears on Visual Performance in Normal Subjects Wearing Contact Lenses 50
10.5.39 Nov 12, 2003: In vitro and Ex Vivo Wettability 50
10.5.40 Jun 03, 2003: Higher Order Ocular Aberrations After Cycloplegic and Non-cycloplegic Pupil Dilation 50
10.5.41 Jun 02, 2003: Minimally Invasive Vitreoretinal Surgery by Small 25-ga instruments 51
10.5.42 Feb 12, 2003: Federal Circuit Court Upholds Lower Court Decision Preventing Sale of PureVision Contact Lenses in the U.S. 51
10.5.43 Dec 12, 2002: Doctor and patient using the Proview eye pressure monitor provide equal reliability 51
10.5.44 May 14, 2002: Zero Compression Heads for Hansatome Microkeratome 51
10.5.45 Mar 28, 2002: AMVISC PRODUCTS 51
10.5.46 Dec 26, 2001: Cataract/Vitreoretinal Surgery 52
10.5.47 Aug 24, 2000: Vision Care: Expectations for category growth have moderated 52
10.5.48 Jun 14, 1999: Bausch & Lomb and Control Delivery Systems Agree to Develop Breakthrough Therapeutic Products for Severe Eye Diseases 52
10.5.49 Dec 31, 1996: Class action complaints 52
10.5.50 Jul 11, 1996: NORVIR/INVIRASE AIDS Study Shows Promising Early Results 53
10.5.51 Dec 08, 1995: Chiron Vision Files FDA Committee Recommendation To Approve Vitrasert Implant . 53
10.5.52 Sep 10, 1995: Legal Proceedings 53
10.6 Clinical Trials 53
10.6.1 Apr 09, 2008: Interim results of hydrophilic acrylic IOL show good visual function, centration 53
11 Appendix 54
11.1 Methodology 54
11.2 About us54
11.3 Contact Us 54
11.4 Disclaimer 54

Executive Summary

1.1 List of Tables
Table 1: Bausch & Lomb Incorporated,Key Facts, 2006 7
Table 2: Bausch & Lomb Incorporated, SWOT Analysis , 2006 14
Table 4: Bausch & Lomb Incorporated, Key Employees, 2006 18
Table 5: Bausch & Lomb Incorporated, Other Locations 21


Companies Mentioned The following companies are the major competitors of Bausch & Lomb Incorporated: Advanced Medical Optics, Inc. Carl Zeiss Meditec AG CIBA Vision Corporation CooperVision, Inc. Essilor International Hoya Corporation Alcon, Inc. Johnson & Johnson Vision Care, Inc.


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/614446

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 13/10/2008 08:34:36
Fax Order Form

To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com


Order information

Please verify that the product information is correct and select the format you require.

Product Name:
Bausch & Lomb Incorporated - Healthcare - Medical Equipment SWOT Report
Web Address:
http://www.researchandmarkets.com/reports/614446
Office Code:
OCHKFPRLUUR

Report formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €92.00
Electronic (PDF) - Site License €185.00
Electronic (PDF) - Enterprisewide €277.00




Contact information

Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World

Research and Markets Page 2 of 2
Printed 13/10/2008 08:34:36

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder Name:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.


If you have a Marketing Code please enter it below:

Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp



Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World